Sernova Corp. (TSE:SVA – Get Free Report)’s stock price was up 21.4% during trading on Wednesday . The company traded as high as C$0.17 and last traded at C$0.17. 276,608 shares changed hands during trading, an increase of 136% from the average session volume of 117,275 shares. The stock had previously closed at C$0.14.
Sernova Trading Down 5.9%
The company’s 50 day simple moving average is C$0.16 and its two-hundred day simple moving average is C$0.15. The company has a quick ratio of 18.11, a current ratio of 0.14 and a debt-to-equity ratio of -25.45. The company has a market capitalization of C$57.84 million, a price-to-earnings ratio of -4.00 and a beta of -0.34.
Sernova Company Profile
Sernova Biotherapeutics is a clinical-stage company developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem-cell derived islet-like clusters in collaboration with Evotec to create bio-hybrid organs to treat T1D. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This innovative approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on T1D and thyroid disorders.
Featured Articles
- Five stocks we like better than Sernova
- Buyback Capacity Is Rising Across 3 Soaring and Sinking Stocks
- How to Invest in the Biggest European Defense Surge in Decades
- The Netflix-Lionsgate Rumor Exposed a Bigger Shift in Media M&A
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
Receive News & Ratings for Sernova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova and related companies with MarketBeat.com's FREE daily email newsletter.
